4 Einträge gefunden

1. Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1)

   1. Blauvelt, Andrew
   2. Kimball, Alexa B
   3. Augustin, Matthias
   4. Okubo, Yukari
   5. Witte, Michael M
   6. Capriles, Claudia Rodriguez
   7. Sontag, Angelina

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Bimekizumab versus Secukinumab in Plaque Psoriasis

   1. Reich, Kristian
   2. Warren, Richard B
   3. Lebwohl, Mark
   4. Gooderham, Melinda
   5. Strober, Bruce
   6. Langley, Richard G
   7. Paul, Carle

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

   1. Gordon, Kenneth B
   2. Strober, Bruce
   3. Lebwohl, Mark
   4. Augustin, Matthias
   5. Blauvelt, Andrew
   6. Poulin, Yves
   7. Papp, Kim A

   2018 - Forschungsinformationssystem des UKE
4. PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

   1. Papp, Kim A
   2. Strober, Bruce
   3. Augustin, Matthias
   4. Calabro, Steve
   5. Londhe, Anil
   6. Chevrier, Marc
   7. Investigators, PSOLAR

   2012 - Forschungsinformationssystem des UKE